By
Drug Target Review2025-08-06T13:30:47
Japanese researchers have engineered a new lipid nanoparticle that delivers mRNA to cells five times more effectively, resulting in stronger immune responses and tumour suppression in mice.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2024-05-10T11:23:31
Sponsored by BellBrook Labs
2026-03-25T15:00:00 2026-03-25T16:00:00
Sponsored by Yokogawa
2023-03-08T16:29:20
Sponsored by Bio-Techne
2026-06-02T15:00:00 2026-06-02T16:00:00
Sponsored by Danaher Life Sciences
2023-07-04T10:05:58
Sponsored by Revvity
2023-05-31T15:16:10
Sponsored by Bio-Techne
Site powered by Webvision Cloud